World Congress of Immunodiseases and Therapy (WCIT-2010)

[kayla]

Dear Friends and Colleagues,

 

We extend a warm welcome to the leading scientists, doctors, industrialists and young researchers to BIT Life Sciences’ 1st Annual World Congress of Immunodiseases and Therapy 2010 (WCIT-2010) with the theme of “Boosting Health and Vitality”, which will take place in Beijing, China on May 15-17, 2010. With your great contributions in the study and research on immunology, you are expected to take part in this international and compositive conference. The program track info at the bottom of the e-mail is for your reference.

WCIT is a focused conference to present and deliberate the advances in immunology, which is significant, timely and important to the health of humanity. The well selected topics cover across disciplinary breaking, from concept to therapy. It is anticipated over 500 global specialists to get together to present and share their cutting-edge technologies and up-to-date researches in an innovative and invigorating combination of presentations, symposia, discussions, panel discussion sessions and associated young scientist poster sessions along with exhibition of technology and new products. The comprehensive and intellectually stimulating scientific program of the first annual will embrace a broad spectrum of topics in basic science, medical research, diagnosis, prevention, clinical treatment and therapy of immune diseases. We believe that WCIT-2010 will definitely provide you an ideal platform for promoting ground breaking research and seeding potential collaborations for relevant parties of tailored interests not only in R & D areas but also the industrial and medical sectors.

The Initiative of WCIT-2010 will include both oral and poster presentations from academic and industrial settings. We hope to set a stage for all the medical doctors, the academicals, the clinical and the industrial researchers to make your research and innovations known with equal opportunity, means to join this event actively.

The capital city, Beijing has long been the political, cultural, scientific and diplomatic center of China. It is both a tribute to China's proud history and a gateway to China's future. Beijing Olympics brought the world a great surprise for the Olympics opening ceremony, WCIT-2010 will be held in Beijing International Convention Center (BICC) which located very near to The National Olympic Sports Center, it's a great advantage to see this amazing place. Also, May is the most pleasant season in spring, you are encourage to have lecture tour to other cities in China.

We look forward to seeing you in Beijing for a stimulating and enjoyable conference!

 

Below is the program track info.

 

Kayla Liu

Program Coordinator

The Organizing Committee of WCIT-2010

 

 

Tentative Program

 

Symposium 1: Research Frontiers on Immune Diseases

Session 1-1: The Immunity Diseases Molecular Mechanisms

Session 1-2: Immunopathology, Etiology and Pathogenic Role of Complement

Session 1-3: Genetics of Immune and Autoimmunity Diseases

Session 1-4: Cell and Molecular Biology of Autoimmunity

Session 1-5: Tumor Immunology

Session 1-6: Innate to Acquired (Adaptive) Immunity and Diseases

Session 1-7: Toll-like Receptors and Pattern Recognition Receptors

Session 1-8: Immune Signal Transduction and Cross-talk

Session 1-9: Immune Regulations- Regulatory T Cells and T Cell Subsets

Session 1-10: Dendritic Cells, Macrophages and other Innate Immune Cells

Session 1-11: Human Immunology and Immunodeficiencies

Session 1-12: Hypersensitivity, Antigen Processing and Presentation

Session 1-13: Immunological Inflammations and Vascular Injury

Session 1-14: Neuroimmunology, Neuroendocrine Immunology and Psychoneuroimmunology

Session 1-15: Natural Killer Cells, Apoptosis & Immunity

Session 1-16: Infection and Immunity, Epidemiology of Immune Diseases

Session 1-17: Prophylaxis and Intervention

Session 1-18: Mucosal Immunology

Session 1-19: Immunochemistry & Immunobiology

Session 1-20: Immune Tolerance in Autoimmune Disease

 

Symposium 2: Leading Technologies in Immunology

Session 2-1: System Biology and Computational Immunology

Session 2-2: Hybridoma Technology

Session 2-3: Sensitivity and Accuracy in Imaging Immunity

Session 2-4: Immunogenomics & Immunoproteomics

Session 2-5: Biochips, Microarray Based Technology

Session 2-6: New Immune Intervention Technologies

Session 2-7: Small RNAs in Development and Immune Diseases

Session 2-8: Nucleic Acids in Innate Immunity

Session 2-9: The Stem Cells and Implications in Immune Diseases

Session 2-10: The SCID Mouse as Model of Immune Diseases

 

 

Symposium 3: Immune Disease Drug Discovery & Development

Session 3-1: Molecular Targets and Biomarkers of Immunotherapeutics

Session 3-2: Computer Aided Drug Design & Medicinal Chemistry

Session 3-3: Immunopharmacology

Session 3-4: Immunosuppression and Immunotherapy Development

Session 3-5: Cytokines, Chemokine and Cell Adhesion Molecules and Drug Discovery

Session 3-6: Gene and Cell Therapy

Session 3-7: Monoclonal Antibody and Antibody Engineering

Session 3-8: Innate Immunity and Novel Vaccines

Session 3-9: Novel Drug Delivery Systems of Immunotherapeutics

Session 3-10: Traditional Medicines for Immune and Inflammatory Diseases

 

Symposium 4: Medical Research and Immune Diseases

Session 4-1: Immunity and Emerging Infectious Disease

Session 4-2: Hormones and Immune Response Mediated Diseases

Session 4-3: Allergy, Asthma & Clinical Immunology

Session 4-4: Autoimmunity Mediated Diseases

Session 4-5: Lymphocyte Development and Functions in Immune Diseases

Session 4-6: Immunosenescence and Clinical Applications

Session 4-7: Immunity and Aging

Session 4-8: Reproductive Immunology

Session 4-9: Neonatal and Maternal Immunization

Session 4-10: Translational Immunology

 

Symposium 5: Diagnostics & Immunotherapy of Major Diseases

Session 5-1: Biomarkers for Molecular Diagnostics of Immune Diseases

Session 5-2: Insulin-Dependent Diabetes Mellitus

Session 5-3: Allergy, Asthma and Rheumatoid Arthritis

Session 5-4: Inflammatory Bowel Disease and Ocular Inflammation

Session 5-5: Vasculitis and Cardiovascular Diseases

Session 5-6: Lung Inflammation and Fibrosis

Session 5-7: Autoimmune Hepatitis and Chronic Liver Diseases

Session 5-8: Multiple Sclerosis, Scleroderma, Myasthenia Gravis, and Neuromuscular Diseases

Session 5-9: Systemic Lupus Erythematosus and and Other Connective Tissue Diseases

Session 5-10: Psoriasis, Allergic Skin Diseases and Immunodermatology

Session 5-11: Immunotherapy on Reemerging TB and Malaria

Session 5-12: Immunological Renal Diseases, and Organ Transplant Rejection

Session 5-13: Major Cancers- Breast Cancer

Session 5-14: Major Cancers-Head, Brain and Neck Cancers

Session 5-15: Major Cancers- Cervical and Ovarian Cancer

Session 5-16: Major Cancers- Pancreatic , Prostate, and Renal Cancer

Session 5-17: Major Cancers- Leukemia, Lymphoma & Melanoma

Session 5-18: Major Cancers- Lung Cancer

Session 5-19: Major Infectious Diseases- HIV/AIDS and Other Viral Infections

Session 5-20: Major Infectious Diseases-Resistant Bacterial Infections

 

Symposium 6: Benchmark Analysis and Case Studies

Session 6-1: Anticancer Drugs

Session 6-2: Anti-inflammatory Drugs

Session 6-3: Anti-allergy and Asthma Drugs

Session 6-4: Anti-Infectious Drugs

Session 6-5: Anti-Autoimmune Drugs

 

Any one who is in this field and being interested please visit our website: http://www.bitlifesciences.com/WCIT2010/default.asp